Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gringeri

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2012
Haemophilia care in Europe: the ESCHQoL studyW Schramm, A Gringeri, R Ljung, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.
AIDS Research and Human Retroviruses|March 19, 1999
Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infectionR Zamarchi, S Indraccolo, S Minuzzo, et al.
Hamostaseologie|October 31, 2013
Development of novel treatment options for patients with haemophiliaH J Ehrlich, W Y Wong, B M Ewenstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitorsJ Astermark, M Morado, A Rocino, et al.
Blood|April 15, 1992
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivoK A Bauer, P M Mannucci, A Gringeri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2007
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study GroupA Nicholson, K Berger, R Bohn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsJ Astermark, A Rocino, M Von Depka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDSD Zagury, A Lachgar, V Chams, et al.
Journal of Human Virology|April 9, 1999
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patientsA Gringeri, E Santagostino, M Muça-Perja, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 30, 2012
Haemophilia care in Europe: the ESCHQoL studyW Schramm, A Gringeri, R Ljung, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Tat toxoid as a component of a preventive vaccine in seronegative subjectsA Gringeri, E Santagostino, M Muça-Perja, et al.
AIDS Research and Human Retroviruses|March 19, 1999
Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infectionR Zamarchi, S Indraccolo, S Minuzzo, et al.
Hamostaseologie|October 31, 2013
Development of novel treatment options for patients with haemophiliaH J Ehrlich, W Y Wong, B M Ewenstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitorsJ Astermark, M Morado, A Rocino, et al.
Blood|April 15, 1992
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivoK A Bauer, P M Mannucci, A Gringeri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 17, 2007
Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study GroupA Nicholson, K Berger, R Bohn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsJ Astermark, A Rocino, M Von Depka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDSD Zagury, A Lachgar, V Chams, et al.
Journal of Human Virology|April 9, 1999
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patientsA Gringeri, E Santagostino, M Muça-Perja, et al.
Pageof 13